Telehealth is showing consistent year-over-year growth as technology is more in demand than ever during the coronavirus crisis.
With the industry-wide push for change in regulations to the commonplace use of video-chat apps, telehealth now has a paved path to widespread adoption; it’s becoming a reality.
The U. S. telehealth market by revenue is expected to grow at a CAGR of over 28% during the period 2020–2026. The adoption of telemedicine is expected to rise with advances in technology and the high penetration of smart gadgets across the US.
USA Equities Corp. (OTCQB: USAQ) is focused on providing value-based healthcare solutions, clinical informatics and algorithmic personalized medicine including digital therapeutics, behavior-based remote patient monitoring, chronic care and preventive medicine.
The Company’s products are intended to allow general practice physicians and other medical practitioners to increase revenues by cost effectively diagnosing and treating chronic diseases that are generally referred to specialists.
The Company’s products and information service portfolio are directed toward prevention, early detection, management and reversal of allergies, cardio-metabolic and other chronic diseases. USAQs principal objectives are to develop proprietary software tools, point of care devices and approaches, providing more granular, timely and specific clinical decision-making information for practicing physicians and other health care providers to address today’s allergy prone, obese, diabetic and cardiovascular disease population.
After acquiring the method patent, trademark and website associated with AllergiEnd®’s diagnostic and allergen immunotherapy product portfolio from MedScience Research Group, Inc., the company announced it has entered into a distribution agreement with a prominent physician management services organization (MSO) for its AllergiEnd® allergy diagnostic and allergen immunotherapy products and services. The MSO will facilitate the working relation between USAQ and its physician members, as well as provide marketing and advertising support. Given the size of the MSO’s member roster, the roll out will be done in stages so as to ensure adequate training and staff support.
Two good reasons why the Telehealth industry will keep on growing:
- Telehealth can reduce the cost of care by eliminating the physical barriers that prevent patients from managing their health over time. As patients continue to take advantage of digital services like remote patient monitoring, automatic appointment reminders, and remote physician consulting using live video and audio, patients can use these services to reduce the cost of care and improve their chances of early detection.
- Increasing Regulatory Approval By Federal agencies like the FDA are starting to approve digital healthcare platforms and services at a faster rate, increasing patient access and competition in the marketplace.
In a recent statement, FDA Commissioner Scott Gottlieb, M.D. encouraged some of the best telemedicine companies to spur innovation in digital health as a way of reducing the cost of care and improving preventative healthcare services. “The new technological paradigm of digital health tools [allows] consumers and providers to supersede the traditional, physical constraints of health care delivery.”
The demand for telehealth services should see tremendous growth over the next few years.
Even after impressive gains over the past six months , shares of USA Equities Corp. (OTCQB: USAQ) are still looking undervalued. That’s why it’s always good to stick a few seedling companies in your portfolio, because even minor share price appreciation can translate to huge percentage gains, and thus, major returns.